AXSM

Bullish

US FDA approves Axsome's drug for Alzheimer's-related agitation

The U.S. FDA has approved Axsome Therapeutics' drug, Auvelity, for treating agitation in patients with Alzheimer's disease. This provides a new treatm...

Reuters 1 week ago 0

Neutral

Axsome Therapeutics (NASDAQ:AXSM) Insider Sells $1,368,150.00 in Stock

Axsome Therapeutics insider Ari Maizel sold 7,500 shares of the company's stock, valued at $1,368,150. This transaction reduced his position by 50%. T...

MarketBeat 2 weeks ago 0